Cardiovascular risks associated with secondline oral antidiabetic agents added to metformin in patients with Type 2 diabetes: a nationwide cohort study

http://www.medworm.com/index.php?rid=108663849&cid=c_64_15_f&fid=33010&url=http%3A%2F%2Fonlinelibrary.wiley.com%2Fresolve%2Fdoi%3FDOI%3D10.1111%252Fdme.12800

Comments are closed.